We recently published a list of the 8 Best Dividend Leaders to Buy According to Wall Street Analysts. In this article, we are ...

Pfizer's oncology promises are several years from being actualized. Read why investors shouldn't assume that a sustained ...

Pfizer trades at a 21.7% discount to peers on a 1-yr forward P/E basis, which is a point for the bullish arguments. Find out ...

We recently compiled a list of the 13 Best Dividend Stocks to Buy Under $50. In this article, we are going to take a look at ...

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest ...

In the latest trading session, Pfizer (PFE) closed at $26.56, marking a -0.67% move from the previous day. The stock's performance was behind the S&P 500's daily loss of 0.04%. Elsewhere, the Dow saw ...

Dividend-paying stocks provide investors with consistent income in turbulent markets, especially as payouts grow over time.

On Friday, Pfizer Inc (PFE) stock saw a modest uptick, ending the day at $26.36 which represents a slight increase of $0.59 or 2.29% from the prior close of $25.77. The stock opened at $ and touched a ...

Below is Validea's guru fundamental report for PFIZER INC (PFE). Of the 22 guru strategies we follow, PFE rates highest using our Shareholder Yield Investor model based on the published strategy ...

On Thursday, Pfizer Inc (PFE) stock saw a decline, ending the day at $25.77 which represents a decrease of $-0.12 or -0.46% from the prior close of $25.89. The stock opened at $25.7 and touched a low ...

In a report released yesterday, Steve Scala from TD Cowen maintained a Hold rating on Pfizer (PFE – Research Report). The company’s shares ...